Kula Investments’s Revolution Medicines RVMD Stock Holding History

Kula Investments’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$470K	Buy	+21,688	New	+$534K	0.12%	328

Other funds holding RVMD

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Kula Investments's RVMD Position: Q1 2023 in Review

Kula Investments opened a new position in Revolution Medicines (RVMD) in Q1 2023: 21,688 shares worth $470K. The stake represents 0.12% of the portfolio and ranks #328 among its holdings.

152 funds tracked by Wall St. Rank hold RVMD as of Q1 2023.

Kula Investments held 21,688 shares of Revolution Medicines worth $470K as of Q1 2023.
Revolution Medicines was a new Kula Investments position in Q1 2023.
Revolution Medicines made up 0.12% of Kula Investments's portfolio in Q1 2023, its #328 holding.
152 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2023.

Based on Kula Investments's 13F filing for Q1 2023, filed 15 May 2023.